The report found the number of deals last year fell from 188 in 2010 to 153 in 2011. Due to the uncertain regulatory environment, investors are more willing to invest in mature companies or companies with devices close to being on the market, the report said.
Related Articles on Medical Devices:
Breast Implant Recall Raises Questions About CE Mark Approval Process
FDA Clears Curos Disinfecting Port Protector
Feds Drop Charges Against Former Stryker Sales Manager
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.